$0.420
-0.018 (-4.22%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Neurosense Therapeutics Ltd (NRSN) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting NRSN is Sell.
Neurosense Therapeutics Ltd (NRSN) 20-Day simple moving average is 0.44, while Neurosense Therapeutics Ltd (NRSN) share price is $—, making it Sell.
Neurosense Therapeutics Ltd (NRSN) 60-Day simple moving average is 0.61, while Neurosense Therapeutics Ltd (NRSN) share price is $—, making it Sell.
Technical Analysis for NRSN
AI Technical NRSNAs of 2026-08-29, the technical board for Neurosense Therapeutics Ltd (NRSN) reads sell: 2 indicators are flashing buy, 7 are indicating sell, and 4 are neutral. Price at $0.42 sits below the 20-day, 60-day and 200-day moving averages and above the 5-day and 10-day.
Momentum readings: RSI stands at 40.098, MACD stands at -0.0524 (Sell), Stochastic %K stands at 63.376, Stochastic %D stands at 54.215 and CCI stands at -20.579.
NRSN trades below the 60-day SMA (0.61) and below the 200-day SMA (0.80). Immediate resistance sits at Classic R1 0.52, then R2 0.65. Support sits at Classic S1 0.26, then S2 0.13.
Neurosense Therapeutics Ltd (NRSN) Support & Resistance Level
Neurosense Therapeutics Ltd (NRSN) Technical Indicators
2026-08-29
| Name | Value |
|---|---|
| RSI_14 | 40.098 |
| STOCHk_14_3_3 | 63.376 |
| STOCHd_14_3_3 | 54.215 |
| CCI_20 | -20.579 |
| AO_5_34 | -0.114 |
| MOM_10 | -0.033 |
| MACD_12_26_9 | -0.052 |
Neurosense Therapeutics Ltd (NRSN) Relative Strength Index (RSI_14) is 40.098, creating a Neutral signal.
Neurosense Therapeutics Ltd (NRSN) Stochastic %K is 63.376, creating a Neutral signal.
Neurosense Therapeutics Ltd (NRSN) Stochastic %D is 54.215, creating a Neutral signal.
Neurosense Therapeutics Ltd (NRSN) CCI_20 is -20.579, creating a Neutral signal.
Neurosense Therapeutics Ltd (NRSN) Awesome Oscillator (AO) is -0.114, creating a Sell signal.
Neurosense Therapeutics Ltd (NRSN) Momentum (MOM) is -0.033, creating a Sell signal.
Neurosense Therapeutics Ltd (NRSN) Moving Average Convergence Divergence (MACD) is -0.052, creating a Sell signal.
Neurosense Therapeutics Ltd (NRSN) Moving Average
2026-08-29
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.405 | Buy |
| MA_10 | 0.396 | Buy |
| MA_20 | 0.441 | Sell |
| MA_60 | 0.611 | Sell |
| MA_200 | 0.800 | Sell |
| MA_250 | 0.874 | Sell |
Neurosense Therapeutics Ltd (NRSN) 5-Day simple moving average is 0.405, while Neurosense Therapeutics Ltd (NRSN) share price is $, making it a Buy.
Neurosense Therapeutics Ltd (NRSN) 10-Day simple moving average is 0.396, while Neurosense Therapeutics Ltd (NRSN) share price is $, making it a Buy.
Neurosense Therapeutics Ltd (NRSN) 20-Day simple moving average is 0.441, while Neurosense Therapeutics Ltd (NRSN) share price is $, making it a Sell.
Neurosense Therapeutics Ltd (NRSN) 60-Day simple moving average is 0.611, while Neurosense Therapeutics Ltd (NRSN) share price is $, making it a Sell.
Neurosense Therapeutics Ltd (NRSN) 200-Day simple moving average is 0.800, while Neurosense Therapeutics Ltd (NRSN) share price is $, making it a Sell.
Neurosense Therapeutics Ltd (NRSN) 250-Day simple moving average is 0.874, while Neurosense Therapeutics Ltd (NRSN) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.